…As Akwa Ibom PSN presents award of commendation

By Chioma Obinna

Prominent figures in Nigeria’s pharmaceutical industry, including the immediate past president of the Pharmaceutical Society of Nigeria (PSN), Prof. Cyril Usifoh, and former PSN President, Mazi Sam Ohuabunwa, among others, have lauded Geneith Pharmaceutical’s innovative contributions towards improving health outcomes with additional seven new products

Speaking during the unveiling of the products at the sideline of the 97th Annual PSN Conference in Uyo, Akwa Ibom State, the industry players said the company has further enhanced the health of the people through the production of quality pharmaceuticals.

The newly launched products, including Sitanom-50/1000, Larykul-Plus, Boneflex Forte, Celoxigen-200, Klinfast Forte, Vildamet-50/1000, and Ceflonac ER 200, were designed to meet a range of therapeutic needs, underscoring Geneith’s dedication to addressing Nigeria’s healthcare challenges.

Unveiling the products, Prof. Cyril Usifoh said Geneith has consistently shown a strong dedication to addressing Nigeria’s healthcare needs through high-quality pharmaceutical products.

He said the launch of the seven products was a testament to their focus on improving lives and setting higher standards in our industry.

Speaking, former Chairman and CEO of Pfizer Nigeria and Neimeth Pharmaceuticals, Pharm Sam Ohuabunwa, said: “When I was invited to the unveiling of these seven new products, I quickly identified with Geneith because the integrity of this company precedes its products.”

Ohuabunwa recalled that Geneith’s Camosunate has gained a strong market presence.

“Geneith has demonstrated a clear, progressive trajectory, from food importation to franchise and contract manufacturing, and now towards local production,” he noted.

Ohuabunwa emphasised the importance of reputation in pharmaceuticals, adding that, “a pharmaceutical product is taken with trust; quality, efficacy, and safety cannot be compromised. If you cut corners, your brand will eventually suffer as people evaluate it to up the effectiveness of what they use. I advise others to ensure quality without compromise, like Geneith, as consistent quality pays off in the long run.”

Speaking, the duo of Pharm. Nsikak Edet Effiong and Pharm. Bede Aguocha Anyanwu underscored the reliability and impact of Geneith Pharmaceuticals’ products on healthcare delivery in Nigeria, saying Geneith is a company known for quality and consistency.

According to Anyanwu, who is a deputy director of Pharmaceutical Services, and head, paediatric outpatient/emergency pharmacy at the UUTH the effectiveness of medication lies in achieving the desired results, and the company’s products deliver on that promise. We see positive outcomes in our patients, and that’s a testament to Geneith’s value to healthcare.”

Effiong, Deputy Director of Pharmaceutical Services, UUTH, also highlighted that Geneith’s products align with Nigeria’s drug policy by meeting the essential criteria of quality, affordability, and availability, and that was the reason the Akwa Ibom State PSN decided to give them an award of best Innovative Pharmaceutical Company.”

Also, Principal Manager (marketing) and Head of Hospital and Institutional Business for Geneith Pharmaceuticals, Pharm. Judith Udeh, said they are known for developing innovative products that stand out in the market.  “In 2024, we introduced seven unique and impactful products, many of which set a standard that others follow. The validation we received from industry leaders, including PSN executives, speaks volumes about our dedication to quality, efficacy, and affordability.”

The Assistant General Manager of Sales and Marketing, Geneith Pharmaceuticals, Pharm. Abimbola Bowoto, said their goal was to showcase Geneith’s distinctiveness in the pharmaceutical industry by offering products that are unparalleled in quality, affordability, and availability.”